Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Atherosclerosis|November 4, 2000
Enhancement of preheparin serum lipoprotein lipase mass by bezafibrate administrationM Totsuka, Y Miyashita, Y Ito, et al.
Atherosclerosis|July 31, 1999
Preheparin serum lipoprotein lipase mass level: the effects of age, gender, and types of hyperlipidemiasH Watanabe, Y Miyashita, T Murano, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|October 7, 1998
[The examination of apoE phenotypes in diabetic patients with peripheral neuropathy]S Tsuzuki, T Murano, H Watanabe, et al.
Japanese Journal of Pharmacology|April 28, 2001
Presence of aldose reductase inhibitors in tea leavesI Sakai, S I Izumi, T Murano, et al.
Journal of Atherosclerosis and Thrombosis|January 1, 1997
Cytotoxicity of some oxysterols on human vascular smooth muscle cells was mediated by apoptosisY Miyashita, K Shirai, Y Ito, et al.
Diabetes Research and Clinical Practice|December 2, 1999
The effect of insulin sensitizer, troglitazone, on lipoprotein lipase mass in preheparin serumK Shirai, Y Itoh, H Sasaki, et al.
Journal of Clinical Pharmacy and Therapeutics|April 7, 2005
Clearance rates of cerivastatin metabolites in a patient with cerivastatin-induced rhabdomyolysisH Ozaki, C T Ishikawa, T Ishii, et al.
Journal of Human Genetics|June 11, 1998
Genomic organization and mapping of the human activin receptor type IIB (hActR-IIB) geneS Ishikawa, M Kai, Y Murata, et al.
Pageof 3